What court cases is Bayer awaiting?

Two major rulings related to Roundup lawsuits are expected soon.

How could the court rulings affect Bayer's stock?

Favorable rulings could boost the stock, while adverse ones may lead to further declines.

Bayer Shares Face Pivotal Court Decisions After $60B Rout

Bayer AG shares are facing a critical few weeks with two upcoming court decisions that could stem the more than $60 billion market value loss since the ill-fated Monsanto purchase eight years ago, according to Bloomberg.

June 12, 2026

2 min read

Source: Bloomberg

Key Numbers

market value wipeout

60B

Bayer AG (BAYN.DE) shares are facing a make-or-break period in the coming weeks, with two upcoming court developments key to stemming a more than $60 billion wipeout in market value since the German company's ill-fated purchase of Monsanto eight years ago, according to Bloomberg.

Details of the Case

The cases relate to lawsuits against Monsanto's Roundup weedkiller, which is alleged to cause cancer. Bayer faces thousands of lawsuits in the U.S. and has set aside billions for settlements.

Context

Since Bayer acquired Monsanto in 2018 for $63 billion, the company's market value has collapsed by over $60 billion due to legal costs and fines. Investors are now awaiting two key rulings that could impact the company's future liability.

What It Means for Investors

The upcoming court decisions will be pivotal for Bayer's stock. Favorable rulings could trigger a rebound, while adverse outcomes may deepen losses. Investors are advised to monitor legal developments closely.

Frequently Asked Questions

Due to the acquisition of Monsanto in 2018 for $63 billion, followed by massive lawsuits related to the Roundup weedkiller.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.